Cost-effectiveness of chronic kidney disease mass screening test in Japan. - Wikidata - awgldk - TriplyDB

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

http://www.wikidata.org/entity/Q35895018

about

Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease Budget impact analysis of chronic kidney disease mass screening test in Japan.Maintenance Dialysis throughout the World in Years 1990 and 2010.Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage Association of a polymorphism of BTN2A1 with chronic kidney disease in community-dwelling individuals Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.Proteinuria Detected by Urine Dipstick Test as a Risk Factor for Atrial Fibrillation: A Nationwide Population-Based Study.Screening Strategies for Unrecognized CKD.Annual incidence of persistent proteinuria in the general population from Ibaraki annual urinalysis study.Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population.Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria.The First Report on the Frequency of Asymptomatic Proteinuria in Iranian School-aged Children.Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey

P2860

Q26783181-D5D50210-100D-4262-827D-759F51127CAF Q33576711-D6ACE4CC-5601-4232-8CC0-DD94F4AFDFB7 Q34737206-E5750F30-F62B-4473-9F54-286198198581 Q36223340-215506BE-171D-4601-828A-40C6AA61C288 Q37206790-FCCDC60B-BA82-453B-9145-511231E3E13B Q37567255-459687BE-DBE0-4CCD-BE86-3C69E12C7288 Q38347571-48A7AB58-E593-4423-ABDF-204E7417D18F Q41108699-922D3454-9004-44EE-B409-86FFB6316BDE Q42743349-E85E9D6F-0C1C-4869-959E-0D7CC648FDF5 Q44492725-43CDE6F9-74FE-4331-8681-A10290CC7CEE Q44688534-51F18AC1-6431-42ED-B378-2DE1F6BC75DF Q47997227-CDE93144-40FC-468D-AF71-C3D3E4D9F789 Q51248518-EB48E6D5-CA3A-4F39-A6D1-85938EF060A0 Q52659172-7D39EF52-083A-4FFD-9F2C-717B160AC514 Q57330479-72A1D6EC-5D4E-454E-9266-570388F8A7E1 Q58362705-7A982CA0-5F39-4544-9162-FE8C531F783B

P2860

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

http://www.wikidata.org/entity/Q35895018

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

@ast

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

@en

type

label

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

@ast

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

@en

prefLabel

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

@ast

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

@en

P1433

Q35895018-53D76FD3-9CC3-4D86-A277-8C74ED58E575

P1476

Q35895018-31D4200E-CC5C-4E23-A282-472547EF8BF3

P2093

Q35895018-0F2E5839-2C63-4660-87BB-66163FD1ACF0

Q35895018-25A463FF-6EA5-4387-B3BC-426832661D07

Q35895018-4480BEF1-E10E-4703-97B5-88746841F2E7

Q35895018-4E0BC2C5-EAC0-43B4-B3BC-1829B99F09D3

Q35895018-83C7B781-25DD-4BF5-B9A2-A59AA997FD9A

Q35895018-9F3147FE-94B2-4115-A501-0CCAD7562628

Q35895018-A28FA09B-F88C-4C26-AC8F-9EA59CA539D8

Q35895018-B6F5E258-1928-4768-A0F3-C4AF68701950

Q35895018-BE4E29FA-57C6-49E8-BE0C-DD966DEEA987

Q35895018-DAA9B9B7-AA45-4329-B84A-C76E05FA506C

P2860

Q35895018-00B675A9-D53C-4A48-A169-739EDC79A3ED

Q35895018-015C1E92-5AC7-4E1D-B3B8-AFA79E1B547B

Q35895018-0886D61F-5F81-44C1-99BE-0E96104AA637

Q35895018-0A67093E-8653-4981-99C3-ED2BB18AA8A7

Q35895018-10B3E6FF-0218-47FA-A19A-D5CE85840B78

Q35895018-10CC7D90-D21E-4AD1-B11E-22FE6E99800F

Q35895018-15A4820C-A327-485C-A777-A6D40567F8FA

Q35895018-2157ADF7-99E1-4138-B480-94C7F2362259

Q35895018-25E46CD8-148D-419C-971B-297654083E96

Q35895018-2CE456B5-F9A9-4AD8-90AE-E000D21DCD06

P2888

Q35895018-53E3A900-3940-41EE-8E56-6A9C783F108A

P304

Q35895018-A2BA6654-5809-49D8-AA3E-6B99CAD550B7

P31

Q35895018-8B86C32A-B584-42BE-80B2-1C6A8054EFA0

P356

Q35895018-4C18723B-B676-4353-BD5E-D95DD3B90D48

P433

Q35895018-FA1F00D8-7031-4C55-AF0A-1D087C7B9665

P478

Q35895018-84490DC1-12A0-48D4-9227-512E9E1DD08C

P577

Q35895018-4F1EDA8B-CA11-42EE-BD49-B260D0452589

P5875

Q35895018-FF1CB6B0-E3C8-4A35-B88F-43EC5576BBAA

P698

Q35895018-B69E8017-4B10-49B8-AFF8-AF50EB83F811

P932

Q35895018-B2F906CD-FABA-4CA5-B92F-26947C99E2C5

P356

S10157-011-0567-1

P1433

Clinical and experimental nephrology

P1476

Cost-effectiveness of chronic kidney disease mass screening test in Japan.

@en

P2093

Chie Saito

http://www.w3.org/2001/XMLSchema#string

Hideaki Yoshida

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Tsuruya

http://www.w3.org/2001/XMLSchema#string

Koichi Asahi

http://www.w3.org/2001/XMLSchema#string

Kunihiro Yamagata

http://www.w3.org/2001/XMLSchema#string

Kunitoshi Iseki

http://www.w3.org/2001/XMLSchema#string

Masahide Kondo

http://www.w3.org/2001/XMLSchema#string

Shu-ling Hoshi

http://www.w3.org/2001/XMLSchema#string

Toshiki Moriyama

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan

Population based screening for chronic kidney disease: cost effectiveness study.

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

Chronic kidney disease: the global challenge.

The organization and financing of end-stage renal disease treatment in Japan.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

Kidney disease screening program in Japan: history, outcome, and perspectives.

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.

Screening for chronic kidney disease: where does Europe go?

P2888

s10157-011-0567-1

P304

279-291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-011-0567-1

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51876538

http://www.w3.org/2001/XMLSchema#string

P698

22167460

http://www.w3.org/2001/XMLSchema#string

P932

3328680

http://www.w3.org/2001/XMLSchema#string